Clinical trials - Press Releases

Date	Title	Company
27-Jun-2023	Taking higher-than-recommended doses of vitamin D for five years reduced the risk of atrial fibrillation	University of Eastern Finland
27-Jun-2023	Shareholders Approve all Board Proposals at Today’s Annual General Meeting	Santhera Pharmaceuticals
27-Jun-2023	Researchers highlight flaws in COVID-19 weather studies and call for improved publishing practices	The University of Manchester
27-Jun-2023	Immodulon Further Strengthens Leadership Team with the Appointments of Richard Couch as Chief Technology Officer and Owen Vaughan as Chief Regulatory Officer	Immodulon Therapeutics Ltd
27-Jun-2023	Astraveus raises €16.5 Million Series Seed round to advance the development of its automated, microfluidic Cell and Gene Therapy manufacturing platform	Astraveus SAS
27-Jun-2023	Cresset Creates New Vice President Role to Lead their Discovery CRO Business	Cresset
27-Jun-2023	Bloomsbury Genetic Therapies Completes Successful Scientific Advice Meeting with the MHRA regarding its BGT-INAD Program	Bloomsbury Genetic Therapies Limited
27-Jun-2023	New report from The King’s Fund shows the UK underperforming on treatable health conditions, says the ABPI	ABPI
27-Jun-2023	Researchers reveal mechanism of protection against breast and ovarian cancer	Francis Crick Institute
27-Jun-2023	Fewer than 1% of Type 2 Diabetes patients participate in clinical trials - despite more than 1 in 10 of US population living with the condition	Lindus Health
22-Jun-2023	Hemophilia Federation of America Launches Clinical Trial Finder Powered by Citeline Connect	Citeline
22-Jun-2023	Poolbeg Pharma Plc Oral Vaccine Programme Moves Forward	Poolbeg Pharma Plc
22-Jun-2023	PSYCH Symposium 2023: Unlocking the potential of psychedelic medicine on 6th July 2023	PSYCH Symposium
22-Jun-2023	Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis	Imcyse
22-Jun-2023	Birmingham research contributes to World Rugby’s international player welfare campaign	University of Birmingham
22-Jun-2023	Alchemab Therapeutics unveils Alzheimer’s candidate ATLX-1088 targeting CD33 at the Antibody Industrial Symposium	Alchemab Therapeutics
22-Jun-2023	The UK must start universal screening for three common genetic conditions at age 30, says expert	US medical journal
22-Jun-2023	Real-world study from Koa Health finds context is key factor in how smartphone use impacts wellbeing	Koa Health
22-Jun-2023	Spaulding Clinical Expands Services to Include ADME Clinical Trials	Spaulding Clinical Research
22-Jun-2023	Accumulus Synergy Appoints Jacques Mascaro as Chair of the Board	Accumulus Synergy